seed
Stage
1
Investors
About
Toregem BioPharma is a Kyoto University-originated startup developing regenerative medicine drugs that induce the growth of natural teeth, focusing initially on congenital tooth agenesis and aiming to expand treatments for oral frailty in elderly patients.
Explore Toregem BioPharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.